RFWD2 Mitigates AD ‐Like Cognitive Impairments via the JNK – SGK1 Signaling Pathway in Mice
CNS Neuroscience & Therapeutics · 2026-04 · 32 (4)
DOI: 10.1002/cns.70860 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 09.04.2026. Verfasst von Mengjiao Ying und 7 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Provincial Center for Neural Regeneration Technology and New Medical Materials Engineering Research, Bengbu Medical University, Bengbu, Anhui, …. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Immediate-Early Proteins, Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Anhui Province, Science Research Project of Bengbu Medical University.
Abstract (Originalsprache)
Background
Alzheimer disease (AD) is a degenerative disorder of the central nervous system. Its main pathological feature is the formation of neurofibrillary tangles through abnormal β‐amyloid protein (Aβ) aggregation and excessive Tau protein phosphorylation. Ring finger and WD repeating domain 2 (RFWD2) is an E3 ubiquitin ligase that regulates neuronal dendrite complexity through the c‐Jun N‐terminal kinase (JNK) pathway. This study aimed to investigate the regulatory effect of RFWD2 on the downstream protein, serum/glucocorticoid‐regulated kinase 1 (SGK1), through the JNK pathway and explore its influence on AD pathogenesis.
Methods
Cognitive‐level behavioral detection was performed in RFWD2 +/− mice. Cultured PC12 cells and cortical neurons were also used to analyze the changes in signaling pathways caused by the decreased expression of RFWD2 in vitro and correlations between the expression of related proteins and key signaling pathways of AD at the molecular level.
Results
Decreased RFWD2 expression led to cognitive deficits in AD mice, resulting in mitochondrial swelling, fragmentation of hippocampal neurons, abnormally high reactive oxygen species levels, and an imbalance between antiapoptotic and proapoptotic proteins. This effect was significantly improved by inhibiting the JNK pathway and SGK1 protein expression. Furthermore, in vitro experiments showed that in PC12 cells and cortical neurons downregulated by RFWD2, the expression levels of p‐JNK, SGK1, and p‐Tau increased, and those of LC3B/Beclin‐1 decreased; ROS levels increased, and apoptosis was induced; inhibiting JNK or SGK1 expression reversed these changes.
Conclusion
RFWD2 regulates SGK1 expression through the JNK pathway, thereby regulating mitochondrial autophagy and apoptosis, altering the expression levels of p‐Tau and Aβ proteins, inducing AD‐like symptoms in mice, and promoting AD development. The RFWD2–JNK–SGK1 axis provides a valuable basis for studying the mechanisms of AD occurrence and developing early intervention strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anhui Provincial Center for Neural Regeneration Technology and New Medical Materials Engineering Research, Bengbu Medical University, Bengbu, Anhui, China.
- School of Life Sciences, Bengbu Medical University, Bengbu, Anhui, China.
- School of Laboratory Medicine, Bengbu Medical University, Bengbu, Anhui, China.
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Pathology, Jinan, Shandong, China.
ORCID-Profile: Mengjiao Ying, Xiaochuan Qi, Ao Wang, Wenhui Tong, Yu Guo
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Anhui Province
- Science Research Project of Bengbu Medical University
- Postgraduate Innovative Training Program of Bengbu Medical University
- Undergraduate Innovative Training Program of China
Zitieren
APA
Ying, M., Qi, X., Wang, A., Zhong, G., Tong, W., Yu, D., Liu, G., & Guo, Y. (2026). RFWD2 Mitigates AD ‐Like Cognitive Impairments via the JNK – SGK1 Signaling Pathway in Mice. CNS Neuroscience & Therapeutics, 32(4). https://doi.org/10.1002/cns.70860
Vancouver
Ying M, Qi X, Wang A, Zhong G, Tong W, Yu D, et al. RFWD2 Mitigates AD ‐Like Cognitive Impairments via the JNK – SGK1 Signaling Pathway in Mice. CNS Neuroscience & Therapeutics. 2026;32(4). doi:10.1002/cns.70860
BibTeX
@article{Ying2026,
author = {Ying, Mengjiao and Qi, Xiaochuan and Wang, Ao and Zhong, Guangshang and Tong, Wenhui and Yu, Danting and Liu, Gaofeng and Guo, Yu},
title = {RFWD2 Mitigates AD ‐Like Cognitive Impairments via the JNK – SGK1 Signaling Pathway in Mice},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {4},
doi = {10.1002/cns.70860}
}
EUVIMED